$128.92
arrow_drop_down3.62%Key Stats | |
---|---|
Open | $134.00 |
Prev. Close | $133.77 |
EPS | 0.75 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 126.82 | 134.55 |
52 Week Range | 55.25 | 173.25 |
Ratios | |
---|---|
EPS | 0.75 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology
Here's How Much $100 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today - Sarepta Therapeutics ... - Benzinga
Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News? - The Motley Fool
1 Soaring Growth Stock to Buy and Hold for 10 Years - The Motley Fool
Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates